Guillain Barré syndrome precipitated by the use of antilymphocyte globulin in the treatment of severe aplastic anaemia
- PMID: 16126887
- PMCID: PMC1770826
- DOI: 10.1136/jcp.2004.020354
Guillain Barré syndrome precipitated by the use of antilymphocyte globulin in the treatment of severe aplastic anaemia
Abstract
This report describes the case of a 54 year old woman with very severe aplastic anaemia who was treated with antilymphocyte globulin (ALG) and developed Guillain Barré syndrome (GBS). No antecedent infective aetiology was identified. Although there are numerous reports of autoimmune disease after treatment with ALG in aplastic anaemia, and GBS after immunosuppressive treatment, there are none reporting GBS after the use of ALG for severe aplastic anaemia. The occurrence of autoimmune disease after immunosuppressive treatment, in particular ALG, is discussed, together with the possible mechanisms that result from T cell depression.
References
-
- Bulsara KR, Baron PW, Tuttle-Newhall JE, et al. Guillain Barré syndrome in organ and bone marrow transplant patients. Transplantation 2001;71:1169–72. - PubMed
-
- Lisak RP, Mitchell M, Zweiman B, et al. Guillain Barré syndrome and Hodgkin’s disease: three cases with immunological studies. Ann Neurol 1977;1:72–8. - PubMed
-
- Re D, Schwenk A, Hegener P, et al. Guillain Barré syndrome in a patient with non Hodgkin’s lymphoma. Ann Oncol 2000;11:217–20. - PubMed
-
- Wilson JR, Conwit RA, Eidelman BH, et al. Sensorimotor neuropathy resembling CIDP in patients receiving FK506. Muscle Nerve 1994;17:528. - PubMed
-
- Palmer BF, Toto RD. Severe neurological toxicity induced by cyclosporin A in three renal transplant patients. Am J Kidney Dis 1991;18:116–21. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical